Currently out of the existing stock ratings of Catherine Novack, 10 are a BUY (90.91%), 1 are a HOLD (9.09%).

Catherine Novack

Work Performance Price Targets & Ratings Chart

Analyst Catherine Novack, currently employed at JONESTRADING, carries an average stock price target met ratio of 53.33% that have a potential upside of 40.27% achieved within 123 days.

Catherine Novack’s has documented 20 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on WVE, Wave Life Sciences Ltd at 25-Sep-2024.

Wall Street Analyst Catherine Novack

Analyst best performing recommendations are on WVE (WAVE LIFE SCIENCES LTD).
The best stock recommendation documented was for WVE (WAVE LIFE SCIENCES LTD) at 8/9/2024. The price target of $12 was fulfilled within 68 days with a profit of $6.59 (121.81%) receiving and performance score of 17.91.

Average potential price target upside

DARE Dare Bioscience KZR Kezar Life Sciences ALDX Aldeyra The FEMY Femasys WVE Wave Life Sciences Ltd

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$12

$9.1 (313.79%)

$12

7 days ago
(01-Apr-2025)

13/17 (76.47%)

$9.1 (313.79%)

198

Buy

$13

$10.1 (348.28%)

$5

7 months 23 days ago
(16-Aug-2024)

2/3 (66.67%)

$9.43 (264.15%)

149

Hold

$4

7 months 25 days ago
(14-Aug-2024)

1/1 (100%)

$-15.44 (-79.42%)

660

Buy

$3

$0.1 (3.45%)

10 months 24 days ago
(15-May-2024)

2/2 (100%)

$-1.32 (-30.56%)

135

Buy

$2

$-0.9 (-31.03%)

$9

1 years 7 months 9 days ago
(30-Aug-2023)

1/2 (50%)

$-6.52 (-76.53%)

713

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Catherine Novack?

On 2022

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?